Literature DB >> 8424463

Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis.

R M Heuertz1, C A Piquette, R O Webster.   

Abstract

In previous studies, we have shown that C-reactive protein (CRP) inhibits chemotaxis of neutrophils to complement fragments in vitro. To evaluate the effect of CRP on C5a-induced inflammation in vivo, a rabbit model of alveolitis was used. Rabbits pretreated with subcutaneous injections of croton oil had serum CRP increase from undetectable levels to 270 +/- 70 micrograms/ml 48 hours later. Rabbits were intubated and C5a des arg (10 micrograms/ml) instilled directly into the lungs via an endotracheal tube. Four to six hours later, the animals were killed and bronchoalveolar lavage performed. Rabbits pretreated with croton oil had significantly (P < 0.01) reduced C5a des arg-stimulated neutrophil infiltration (30 +/- 5%) into alveolar air spaces compared to untreated rabbits (64 +/- 9%). Increased numbers of total leukocytes in the alveolar washes coincided with increased neutrophil numbers whereas alveolar macrophages remained unchanged in all groups. Rabbits pretreated with croton oil also had a significant decrease (P < 0.05) in total protein (320 +/- 50 micrograms/ml) in lavage fluid after C5a instillation compared with untreated animals (850 +/- 140 micrograms/ml). In vitro, rabbit CRP (50 micrograms/ml) added to normal rabbit serum significantly (P < 0.05) inhibited chemotaxis of human neutrophils by 41%. Finally, direct intravenous pretreatment of rabbits with purified CRP also significantly reduced C5a-induced alveolitis. The CRP-C5a group had 33 +/- 10% neutrophil infiltration, a significant (P < 0.01) reduction from the C5a group (71 +/- 6%). The total protein content of the CRP-C5a rabbits was 986 +/- 165 micrograms/ml in the lavage fluid, which was significantly (P < 0.05) lower than the C5a group (1645 +/- 363 micrograms/ml). Therefore, CRP inhibits the development of neutrophil alveolitis and protein leakage in vivo and inhibits neutrophil chemotaxis in vitro. These data indicate that CRP offers a protective effect in neutrophil-mediated lung injury by reducing neutrophil influx and protein leak.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424463      PMCID: PMC1886843     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Interactions of C-reactive protein with the first component of human complement.

Authors:  D R Claus; J Siegel; K Petras; A P Osmand; H Gewurz
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

2.  Intra-assay complement activation may falsely indicate the presence of chemotactic factors in a test plasma or serum.

Authors:  K Bergh; O J Iverson
Journal:  J Immunol Methods       Date:  1989-09-29       Impact factor: 2.303

3.  Rabbit CRP response to endotoxin administration: dose-response relationship and kinetics.

Authors:  B Yen-Watson; I Kushner
Journal:  Proc Soc Exp Biol Med       Date:  1974-09

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Primary structure of rabbit C-reactive protein.

Authors:  C M Wang; N Y Nguyen; K Yonaha; F Robey; T Y Liu
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

6.  Mediation of CRP-dependent phagocytosis through mouse macrophage Fc-receptors.

Authors:  R F Mortensen; J A Duszkiewicz
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

7.  Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis.

Authors:  T W Du Clos; C Mold; P Y Paterson; J Alroy; H Gewurz
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

8.  C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro.

Authors:  F A Robey; K D Jones; A D Steinberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

9.  The liver as the site of C-reactive protein formation.

Authors:  J Hurlimann; G J Thorbecke; G M Hochwald
Journal:  J Exp Med       Date:  1966-02-01       Impact factor: 14.307

10.  Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions.

Authors:  I KUSHNER; M H KAPLAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  15 in total

Review 1.  C-reactive protein as a pro-inflammatory mediator in cardiovascular disease by its ability to activate complement: additional proof and hypothetical mechanisms.

Authors:  W K Lagrand; R Nijmeijer; H W M Niessen; C A Visser; W Th Hermens; C E Hack
Journal:  Neth Heart J       Date:  2002-04       Impact factor: 2.380

2.  Interleukin-6 deficiency increases inflammatory bone destruction.

Authors:  K Balto; H Sasaki; P Stashenko
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein.

Authors:  C Zouki; M Beauchamp; C Baron; J G Filep
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo.

Authors:  Devipriya Subramaniyam; Chad Steele; Thomas Köhnlein; Tobias Welte; Olof Grip; Sadis Matalon; Sabina Janciauskiene
Journal:  Inflamm Res       Date:  2010-03-18       Impact factor: 4.575

5.  Plasma C-reactive protein levels are associated with improved outcome in ARDS.

Authors:  Ednan K Bajwa; Uzma A Khan; James L Januzzi; Michelle N Gong; B Taylor Thompson; David C Christiani
Journal:  Chest       Date:  2009-05-01       Impact factor: 9.410

6.  An online nomogram of acute respiratory distress syndrome originating from pulmonary disease.

Authors:  Hanghang Wang; Wen Tang; Quanyue Hu; Hao Hu; Rui Tang; Jia Deng; Daoxin Wang; Yan Zhao
Journal:  Eur J Clin Invest       Date:  2021-11-17       Impact factor: 5.722

7.  Serum amyloid P inhibits granulocyte adhesion.

Authors:  Anu S Maharjan; David Roife; Derrick Brazill; Richard H Gomer
Journal:  Fibrogenesis Tissue Repair       Date:  2013-01-17

8.  Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality.

Authors:  C Libert; P Brouckaert; W Fiers
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

9.  C-reactive protein: a physiological activator of interleukin 6 receptor shedding.

Authors:  S A Jones; D Novick; S Horiuchi; N Yamamoto; A J Szalai; G M Fuller
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

10.  Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.

Authors:  H Tilg; E Vannier; G Vachino; C A Dinarello; J W Mier
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.